ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01448720
Recruitment Status : Completed
First Posted : October 7, 2011
Last Update Posted : September 18, 2014
Sponsor:
Information provided by (Responsible Party):
Janssen-Cilag Farmaceutica Ltda.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013